News & Events

Franklin Lakes, NJ (May 30, 2000) -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced that John R. Considine has been named Executive Vice President and Chief Financial Officer. The appointment follows an external search undertaken by the company to replace Kenneth R. Weisshaar, former senior vice president and chief financial officer.

“BD is committed to playing a major role in driving improvements in medical practice and achieving our performance goals. We conducted a careful and thoughtful search to identify a person with the right mix of financial acumen and global health care expertise to lead our financial organization - in John Considine we have found that person,” said BD President and Chief Executive Officer Edward J. Ludwig. “John is a dynamic, seasoned leader with a proven track record in financial and executive management, the respect of Wall Street, extensive experience in global health care and the personal attributes we value at BD. It is a pleasure to welcome him to our leadership team.”

Considine, 50, joins BD from American Home Products (AHP), where he was Senior Vice President, Finance. He will be responsible for executive management and oversight of BD’s global financial operations, reporting directly to Ludwig.

“I am pleased and excited to assume the senior financial leadership position at BD, a health care company with a wonderful heritage that is recognized as a provider of essential medical products around the world,” said Considine. “BD is poised to capitalize on its manufacturing know-how, knowledge of medical practice, and winning market development strategies and emerge as an even more important contributor to human health and a great performing company. I look forward to working towards our future success with Ed Ludwig and his key leadership team.”

During Considine’s 17 years at AHP he served in various financial management positions, including leading the company’s Controllership, Treasury, Investor Relations, and Internal Audit groups. He was also a member of AHP’s Finance, Retirement and Operations Committees and a member of the Board of Directors of Immunex (NASDAQ: IMNX), AHP’s majority-owned biopharmaceutical subsidiary. Prior to joining AHP, Considine spent ten years with the public accounting firm of Arthur Andersen & Company.

A native of Stamford, Connecticut, Considine attended Villanova and Pace Universities. He is a Board Member of the Animal Cancer Foundation and an honorary Board Member of St. Vincent’s Services.

BD is a medical technology company that manufactures and sells a broad range of supplies, devices and systems for use by health care professionals, medical research institutions, industry and the general public. For the fiscal year ended September 30, 1999, BD reported total revenues of $3.4 billion and net income of $276 million.